Insider trades
Paul J. Diaz, CEO of Myriad Genetics MYGN, has filed 0 purchases and 5 sales on the open market. The latest trade was on 25/03/24.
Paul J. Diaz
President and CEO
- Company
- Myriad Genetics MYGN
- First filing
- 23/03/17
- Trades
- 27 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- No record
- Last trade
- 25/03/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Myriad GeneticsMYGN | Open-market sale10b5-1 plan | 24/10/11 | 24/10/11 | 15,000 sh | $22.93 | $343,950 | −1.5% |
Myriad GeneticsMYGN | Open-market sale10b5-1 plan | 24/09/11 | 24/09/12 | 15,000 sh | $26.72 | $400,800 | −1.5% |
MYGN | Open-market sale | 24/05/13–24/05/15 | 24/05/15 | 227,844 sh3 trades | $25.14avg. | $5,728,819.72 | −17.6% |